75 related articles for article (PubMed ID: 26238155)
21. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
22. Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma.
Lin DC; Xu L; Chen Y; Yan H; Hazawa M; Doan N; Said JW; Ding LW; Liu LZ; Yang H; Yu S; Kahn M; Yin D; Koeffler HP
Cancer Res; 2015 May; 75(9):1815-27. PubMed ID: 25877876
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
24. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
[TBL] [Abstract][Full Text] [Related]
25. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
26. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.
Huettner C; Paulus W; Roggendorf W
Am J Pathol; 1995 Feb; 146(2):317-22. PubMed ID: 7856743
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of anti-LRRC4 polyclonal antibody and its application in constructing expression profile of human gliomas with different pathological grades].
Li D; Wu MH; Chen Q; Huang H; Huang C; Li WS; Li XL; Li GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):373-9. PubMed ID: 17611308
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
Li S; Yang B; Li G; He S; Li Y
Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
30. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
31. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
32. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
[TBL] [Abstract][Full Text] [Related]
33. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
34. Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival.
Warth A; Simon P; Capper D; Goeppert B; Tabatabai G; Herzog H; Dietz K; Stubenvoll F; Ajaaj R; Becker R; Weller M; Meyermann R; Wolburg H; Mittelbronn M
J Neurosci Res; 2007 May; 85(6):1336-46. PubMed ID: 17335082
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of annexin 2 decreases migration of human glioma cells in vitro.
Tatenhorst L; Rescher U; Gerke V; Paulus W
Neuropathol Appl Neurobiol; 2006 Jun; 32(3):271-7. PubMed ID: 16640645
[TBL] [Abstract][Full Text] [Related]
36. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
37. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of fibroblast growth factor receptor 2 and its isoforms correlates with a high proliferation rate and poor prognosis in high-grade glioma.
Ohashi R; Matsuda Y; Ishiwata T; Naito Z
Oncol Rep; 2014 Sep; 32(3):1163-9. PubMed ID: 24968791
[TBL] [Abstract][Full Text] [Related]
39. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
40. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
